Table 4.
Studies contributing effect size data for the meta-analysis of alerting attention-response time
Study | Task/outcome | Hedges’s g | Standard error | n | Agea | % male | Smoking status | Cigarettes per daya | Nicotine dose, mg | Route of administration |
---|---|---|---|---|---|---|---|---|---|---|
Barr et al. 2008b | Signal detection | 0.38 | 0.19 | 30 | 39 | 53 | NSm | NA | 14 | Transdermal |
Bates et al. 1995 | Choice RT | 0.47 | 0.23 | 19 | 21 | 32 | Sm | 5–25 | 0.8 | Inhalation-cigarette |
File et al. 2001 | RVIP | 0.37 | 0.35 | 32 | 21 | 50 | NSm | NA | 2 | Inhalation-inhaler |
Foulds et al. 1996b | RVIP | 1.42 | 0.33 | 18 | 25 | 50 | NSm | NA | 0.6 | Subcutaneous |
Kelemen and Fulton 2008 | RVIP | 0.28 | 0.18 | 32 | 24 | 69 | Sm | >10 | 2 | Buccal |
Kleykamp et al. 2005b | ANT | −0.16 | 0.22 | 20 | 20 | 45 | NSm | NA | 4 | Buccal |
Lawrence et al. 2002 | RVIP | 0.07 | 0.24 | 15 | 22 | 53 | Sm | 22 | 21 | Transdermal |
Le Houezec et al. 1994 | Choice RT | 0.50 | 0.29 | 12 | 27 | 100 | NSm | NA | 0.8 | Subcutaneous |
Levin et al. 1998 | CPT | 0.10 | 0.28 | 11 | 23 | 91 | NSm | NA | 7 | Transdermal |
Myers et al. 2008b | CPT | 0.27 | 0.20 | 25 | 36 | 52 | Sm | 22 | 2 | Intranasal |
Poltavski and Petros 2006 | CPT | 0.38 | 0.36 | 30 | 20 | 100 | NSm | NA | 7 | Transdermal |
Rusted and Alvares 2008 | RVIP | 0.64 | 0.29 | 48 | 22 | 44 | NSm | NA | 1 | Intranasal |
Thiel et al. 2005b | Cued target detection | 0.27 | 0.22 | 19 | 24 | 42 | NSm | NA | 2 | Buccal |
Nsm nonsmoker, Sm smoker, NA not applicable, RVIP rapid visual information processing, ANT attention network test, CPT continuous performance test
Mean value
Administered multiple active nicotine doses